1:17cv774 • November 15, 2017
Class Period Start
March 24, 2016
Class Period End
January 19, 2018
PSLRA Deadline
January 16, 2018
Case Allegations
10b5
Statutes of Repose
Mar 24, 2019
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
February 4, 2020
Settlement Fund
$2,100,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased Meridian Bioscience, Inc. (“Meridian”) securities between March 24, 2016 and October 23, 2017, inclusive.
Claim Administrator
Meridian Bioscience Sec. Litig
c/o A.B. Data, Ltd.
P.O. Box 173081
Milwaukee, WI 53217
+1 800-331-8642
[email protected]
Settlement Website
-Hearing Date
March 16, 2020
Opt-out Deadline
February 14, 2020
Settlement Note
Download hereProof Of Claim
Download here
Dec 29, 2020
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Mar 17, 2020
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Nov 6, 2019
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Oct 9, 2019
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
May 20, 2019
Motion to Dismiss Denied in Part
The court has determined that plaintiffs have adequately alleged some of their claims, but have failed to adequately allege other claims. The judge has therefore denied in part the motion to dismiss filed by defendants and written an order stating which claims are dismissed and which remain. The case will proceed and parties will litigate the remaining claims.
Feb 13, 2019
The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.
Jun 15, 2018
After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.
Apr 16, 2018
A new complaint has been filed on behalf of certain investors in VivoPower PLC. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.
Feb 15, 2018
The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.
Nov 15, 2017
A securities fraud class action complaint has been filed on behalf of certain investors in VivoPower PLC.
TOP
